Fig. 3From: Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinomaEvaluation of prognostic signature. The 1-, 2-, and 3-year ROC curves of prognostic signature in the training (A) and test (B) groups. K–M curve for OS of two risk groups in stage I–II patients (C) and stage III–IV patients (D)Back to article page